Authors: EHRKE MJ VERSTOVSEK S ZALESKIS G HO RLX UJHAZY P MACCUBBIN DL MIHICH E

Citation: Mj. Ehrke et al., SPECIFIC ANTI-EL4-LYMPHOMA IMMUNITY IN MICE CURED 2 YEARS EARLIER WITH DOXORUBICIN AND INTERLEUKIN-2, Cancer immunology and immunotherapy, 42(4), 1996, pp. 221-230

Authors: ZALESKIS G HO RLX DIEGELMAN P MACCUBBIN D UJHAZY P MIHICH E EHRKE MJ

Citation: G. Zaleskis et al., INTRACELLULAR DOXORUBICIN KINETICS IN LYMPHOMA-CELLS AND LYMPHOCYTES INFILTRATING THE TUMOR AREA IN-VIVO - A FLOW CYTOMETRIC STUDY, Oncology research, 6(4-5), 1994, pp. 183-194

Authors: HO RLX MACCUBBIN DL UJHAZY P ZALESKIS G EPPOLITO C MIHICH E EHRKE MJ

Citation: Rlx. Ho et al., IMMUNOLOGICAL RESPONSES CRITICAL TO THE THERAPEUTIC EFFECTS OF ADRIAMYCIN PLUS INTERLEUKIN-2 IN C57BL 6 MICE BEARING SYNGENEIC EL4 LYMPHOMA/, Oncology research, 5(9), 1993, pp. 363-372

Authors: HO RLX MACCUBBIN D ZALESKIS G KRAWCZYK C WING K MIHICH E EHRKE MJ

Citation: Rlx. Ho et al., DEVELOPMENT OF A SAFE AND EFFECTIVE ADRIAMYCIN PLUS INTERLEUKIN-2 THERAPY AGAINST BOTH ADRIAMYCIN-SENSITIVE AND ADRIAMYCIN-RESISTANT LYMPHOMAS, Oncology research, 5(9), 1993, pp. 373-381